REPO4EU begins its journey to push the boundaries of drug repurposing
The first step in the journey from imprecise drug therapy to precision medicine – REPO4EU’s Euro/Global Platform for Drug Repurposing
The consortium of REPO4EU (Precision drug REPurpOsing For EUrope and the world) is pleased to announce the launch of an ambitious joint initiative selected and granted almost €23M by the European Commission as part of the Horizon Europe Programme.
REPO4EU’s ultimate goal is to build and grow an industry-level European online platform for validated precision drug repurposing with a global reach. This platform will operate as the go-to data hub for key information, training resources, matchmaking and cooperation in drug repurposing.
The platform will provide extensive expertise throughout the whole value chain in drug repurposing: from freedom-to-operate analysis to intellectual property protection and business development, health technology assessment, ethics and data governance considerations.
During the next 7 years, 28 partners from 10 countries (The Netherlands, Germany, Austria, Spain, Sweden, Romania, Belgium, Portugal, Switzerland and the United States) will join forces to make REPO4EU a reality and create a unique platform for drug repurposing, pooling stakeholders and expertise at a global stage to create a “made in Europe”, fully-fledged infrastructure for drug repurposing.
Sounds interesting?
You can check out our first joint press release in the link below
Our first press release is out!
Many exciting things are on the horizon for this September that we would like to share with everyone in the drug repurposing community!
REPO4EU - the Euro-Global platform for Mechanism-based Drug Repurposing is officially kicking off next month and with it also comes to life RExPO22 - the first international conference on drug repurposing.
You can read all about it in our first joint press release!